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ST waveform analysis of fetal electrocardiogram (ECG) for
intrapartum surveillance (STAN) is a newly introduced method for
fetal surveillance. The purpose of this commentary is to assist in
the proper use of fetal ECG in combination with cardiotocography
(CTG) during labour. Guidelines and recommendations
concerning CTG and ST waveform interpretation and classiﬁcation
are stated that were agreed on by the European experts on ST
waveform analysis for intrapartum surveillance during a meeting in
Utretcht, the Netherlands in January 2007.
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The technique was developed in Sweden and has widespread
use in Scandinavia with the help of ‘expert’ centres, which
help in education and training. It is used to a lesser extent
over the rest of Europe and has recently been approved by the
Food and Drug Administration for use in the USA.
With the introduction of this new technique, pitfalls,
limitations and user errors have emerged with extended
use. The two articles in this issue of the BJOG draw atten-
tion to these.1,2 To resolve such issues arising from some
cases in Scandinavia, a Nordic meeting took place in
November 2006, and European problems were discussed
during a European meeting in Utrecht, the Netherlands,
in January 2007. A general agreement was reached that fetal
heart rate (FHR) interpretation was still the main problem.
Decision making with the STAN technology uses computer
analysis of the electrocardiogram (ECG) with visual inter-
pretation of the cardiotocogram (CTG). The expert group
recommended slight revision of the STAN guidelines and
measures to overcome user errors to reduce ambiguity and
the risk of adverse outcome. This commentary outlines
these recommendations.
Prerequisites for initiation of
STAN monitoring
A checklist was suggested to be used at the start of recording
(Table 1). STAN calculates the initial reference baseline
T/QRS using the ﬁrst 20 T/QRS data recorded and resets
the baseline if it becomes lower or after 3 hours of recording.
A ST rise is detected when a sequence of T/QRS data are
recorded, which signiﬁcantly exceeds this T/QRS baseline,
and an ST event is ﬂagged by the computer. In a case of
pre-existing fetal hypoxia, the ST change may have already
taken place and further ST rise may not occur. Therefore,
STAN recordings should start during the ﬁrst stage of labour,
with ideally a reassuring FHR trace.
Based on a large prospective study where acid–base values
were evaluated with CTG and ECG changes, the expert group
considers it acceptable to start STAN monitoring on a non-
reassuring CTG trace if the previous FHR pattern includes
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Abnormal FHR at the start of recording without previous
FHR information requires assessment of the fetal state prior
to the application of STAN, for example analysis of fetal scalp
pH and/or FHR reactivity with digital or vibroacoustic stim-
ulation. Absence of ST events in a situation with nonreassur-
ing FHR trace from the start could be related to previous
compromise in a fetus that is unable to respond with ECG
changes. If additional assessment of the fetal condition in such
a case is not possible, the need for intervention should be
based on FHR, clinical situation and fetal blood sampling
(FBS) but not on STAN information.
Signal quality
Fetal ECG ST analysis requires good signal quality. Continu-
ous data (with at least one T/QRS ratio/minute) are needed to
obtain reliable ST information. Gaps in the T/QRS ratios for
more than 4 minutes may result in missed STAN events. This
is particularly important in the presence of intermediary or
abnormal FHR and during second stage when the condition
of the fetus may deteriorate rapidly.
Disconnection of ST waveform
analysis
The reference T/QRS baseline calculated previously is kept
when the machine is temporarily disconnected by using the
‘temporary end’ function. However, ST events that may occur
during the disconnected period will not be detected. There-
fore, pausing a recording when the FHR is abnormal is not
recommended, as signiﬁcant STAN events may be missed. If
the FHR has become abnormal during temporary disconnec-
tion, the situation maybe similar to starting a recording with
an abnormal trace, that is there is a need to check the fetal
status using FBS or stimulation tests.
FHR classiﬁcation used with
STAN technology
With the use of STAN, the FHR pattern is classiﬁed according
to the International Federation of Obstetrics and Gynecology
guidelines.3 With a combination of several intermediary
observations, the FHR should be classiﬁed as abnormal
(Table 2). Calling for additional expertise in assessing FHR
should be considered an intervention and is as important as
alleviation of the cause(s) of fetal compromise, such as stop-
ping oxytocin infusion or repositioning of the mother.
Table 2. CTG classiﬁcation
CTG-class Baseline heart rate Variability/reactivity Decelerations
Normal CTG d 110–150 bpm d 5–25 bpm
d Accelerations
d Early uniform decelerations;
d Uncomplicated variable
decelerations with a duration
of ,60 sec and loss of ,60 beats
Intermediary CTG d 100–110 bpm
d 150–170 bpm
d Short bradycardia episode
(,100 bpm for 3 minutes)
d .25 bpm (saltatory pattern)
d ,5 bpm for .40 minutes with
absence of accelerations
d Uncomplicated variable
decelerations with a duration
,60 sec and loss of .60 beats
A combination of several intermediary observations will result in an abnormal CTG
Abnormal CTG d 150–170 bpm and reduced variability
d .170 bpm
d Persistent bradycardia
(,100 bpm for .3 minutes)
d ,5 bpm for .60 minutes
d Sinusoidal pattern
d Complicated variable
decelerations with a duration
of .60 sec
d Repeated late uniform decelerations
Preterminal CTG Total lack of variability (,2 bpm) and reactivity with or without decelerations or bradycardia
bpm, beats per minutes.
Table 1. STanalysis checklist at start-up
Before starting STAN
d .36 1 0 gestational weeks
d Ruptured membranes
d No contraindication for scalp electrode
d First stage, no active or involuntary pushing at onset
After start-up
d Normal ECG waveform with sufﬁcient signal quality
d Event log message baseline determined
d Check for reactivity and nondeteriorating fetal state at the onset
of a STAN recording, classify FHR!
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pattern in the absence of ST events
In rare cases, the FHR pattern may gradually change from
normal to abnormal, without the appearance of ST events
(see paper by Westerhuis et al. in this issue).1 An abnormal
FHR pattern for more than 60 minutes (or earlier if the CTG
deteriorates rapidly) with normal ST requires qualiﬁed assess-
ment and checking for nondeteriorating fetal state (with a
preterminal FHR pattern, intervention is always indicated,
irrespective of the ST data.
Intervention should be undertaken
according the STAN guidelines
Intervention depends on the cause of fetal compromise and
the stage of labour. During the ﬁrst stage, interventions may
consist of intrauterine resuscitation (cessation of oxytocin
infusion and/or acute tocolysis in cases of excessive uterine
contractions), correction of maternal hypotension or
amnioinfusion. A caesarean section is only one of the options.
Recovery requires both CTG and ST to be normalised and
a FBS may be required to verify recovery. During the second
stage of labour with active pushing, immediate operative
delivery is recommended, unless spontaneous delivery is to
be anticipated in the next 5–10 minutes.
In the presence of STAN event and suspicious or abnor-
mal CTG calling for intervention according to the STAN
guidelines, this should be undertaken within 20 minutes
(Table 3).
Maternal fever
STAN is a method for detection of acute intrapartum
asphyxia not fetal infections. In the presence of maternal
pyrexia, even intermediary FHR changes may be regarded as
signiﬁcant in connection with an ST event.
Biphasic ST events
Biphasic (BP) ST events should be considered in relation to
the window of recording. This implies that two BP events in
combination with an abnormal CTG calls for intervention.
The time-spanbetween the BP should be related tothe clinical
situation. Appropriate and consistent classiﬁcation of the
FHR patterns is still the weakest link in intrapartum moni-
toring, as education and training in FHR interpretation is not
as widespread as the method itself.
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Table 3. STAN simpliﬁed clinical guidelines. Intervention
recommended on the basis of CTG abnormalities and STevents*
Intermediary
CTG
Abnormal
CTG
Preterminal
CTG
Episodic T/QRS rise .0.15 .0.10 Immediate
delivery Baseline T/QRS rise .0.10 .0.05
Biphasic ST Three biphasic
STevents
Two biphasic
STevents
*These guidelines are applicable to a term pregnancy of 36
completed gestational weeks or more and indicate situations in
which intervention is required. This means calling for further expertise
in assessing FHR data, alleviation of the cause(s) of fetal distress
(overstimulation with oxytocin or maternal hypotension) or delivery.
During the second stage of labour with active pushing, immediate
operative delivery is recommended, unless spontaneous delivery is
to be anticipated in the next 5–10 minutes.
Fetal ECG in labour
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